Supplementary Figure S5 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial Article Swipe

View

David S. Moura , Jesús M. López Martí , Iva Benešová , Carlos E. de Andrea , Davide di Lernia , Serena Lacerenza , José L. Mondaza-Hernández , Marta Martín‐Ruíz , Marta Ramírez-Calvo , Giovanni Grignani , Javier Martínez‐Trufero , Andrés Redondo , Claudia Valverde , Silvia Stacchiotti , Antonio López–Pousa , José Antonio López‐Guerrero , Antonio Gutiérrez , Victor Encinas-Tobajas , Nadia Hindi , Dario Sangiolo , José A. López-Martín , Zuzana Střížová , Javier Martín‐Broto ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.27754869

Supplementary Figure S5. CXCL10 protein expression in cell culture supernatant. The expression levels of CXCL10 soluble protein were measured after anti-CD3/CD28 stimulation and anti-PD-1 treatment in PBMC cultures (A) and tumor multi-cultures (B). Significance was defined as p<0.05 (Students t-test).

Related Topics

Concepts

Correlative Signature (topology) Soft tissue sarcoma Sarcoma Soft tissue Medicine Internal medicine Oncology Computer science Surgery Pathology Mathematics Philosophy Linguistics Geometry

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.27754869
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4404423516

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4404423516

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.27754869

Digital Object Identifier
Title: Supplementary Figure S5 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-11-15

Full publication date if available
Authors: David S. Moura, Jesús M. López Martí, Iva Benešová, Carlos E. de Andrea, Davide di Lernia, Serena Lacerenza, José L. Mondaza-Hernández, Marta Martín‐Ruíz, Marta Ramírez-Calvo, Giovanni Grignani, Javier Martínez‐Trufero, Andrés Redondo, Claudia Valverde, Silvia Stacchiotti, Antonio López–Pousa, José Antonio López‐Guerrero, Antonio Gutiérrez, Victor Encinas-Tobajas, Nadia Hindi, Dario Sangiolo, José A. López-Martín, Zuzana Střížová, Javier Martín‐Broto

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.27754869

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.27754869

Direct OA link when available
Concepts: Correlative, Signature (topology), Soft tissue sarcoma, Sarcoma, Soft tissue, Medicine, Internal medicine, Oncology, Computer science, Surgery, Pathology, Mathematics, Philosophy, Linguistics, Geometry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4404423516
doi	https://doi.org/10.1158/1078-0432.27754869
ids.doi	https://doi.org/10.1158/1078-0432.27754869
ids.openalex	https://openalex.org/W4404423516
fwci	0.0
type	preprint
title	Supplementary Figure S5 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10253
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9973999857902527
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Sarcoma Diagnosis and Treatment
topics[1].id	https://openalex.org/T11638
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9904000163078308
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2705
topics[1].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[1].display_name	Cardiac tumors and thrombi
topics[2].id	https://openalex.org/T12278
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9891999959945679
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	Vascular Tumors and Angiosarcomas
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2776800370
concepts[0].level	2
concepts[0].score	0.7673544883728027
concepts[0].wikidata	https://www.wikidata.org/wiki/Q5172864
concepts[0].display_name	Correlative
concepts[1].id	https://openalex.org/C2779696439
concepts[1].level	2
concepts[1].score	0.639998197555542
concepts[1].wikidata	https://www.wikidata.org/wiki/Q7512811
concepts[1].display_name	Signature (topology)
concepts[2].id	https://openalex.org/C2778629024
concepts[2].level	3
concepts[2].score	0.5806832313537598
concepts[2].wikidata	https://www.wikidata.org/wiki/Q720020
concepts[2].display_name	Soft tissue sarcoma
concepts[3].id	https://openalex.org/C2778256501
concepts[3].level	2
concepts[3].score	0.48752138018608093
concepts[3].wikidata	https://www.wikidata.org/wiki/Q223911
concepts[3].display_name	Sarcoma
concepts[4].id	https://openalex.org/C136948725
concepts[4].level	2
concepts[4].score	0.4454762935638428
concepts[4].wikidata	https://www.wikidata.org/wiki/Q1458306
concepts[4].display_name	Soft tissue
concepts[5].id	https://openalex.org/C71924100
concepts[5].level	0
concepts[5].score	0.4198082387447357
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[5].display_name	Medicine
concepts[6].id	https://openalex.org/C126322002
concepts[6].level	1
concepts[6].score	0.37550005316734314
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[6].display_name	Internal medicine
concepts[7].id	https://openalex.org/C143998085
concepts[7].level	1
concepts[7].score	0.36900174617767334
concepts[7].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[7].display_name	Oncology
concepts[8].id	https://openalex.org/C41008148
concepts[8].level	0
concepts[8].score	0.33658313751220703
concepts[8].wikidata	https://www.wikidata.org/wiki/Q21198
concepts[8].display_name	Computer science
concepts[9].id	https://openalex.org/C141071460
concepts[9].level	1
concepts[9].score	0.21260696649551392
concepts[9].wikidata	https://www.wikidata.org/wiki/Q40821
concepts[9].display_name	Surgery
concepts[10].id	https://openalex.org/C142724271
concepts[10].level	1
concepts[10].score	0.20856687426567078
concepts[10].wikidata	https://www.wikidata.org/wiki/Q7208
concepts[10].display_name	Pathology
concepts[11].id	https://openalex.org/C33923547
concepts[11].level	0
concepts[11].score	0.13109853863716125
concepts[11].wikidata	https://www.wikidata.org/wiki/Q395
concepts[11].display_name	Mathematics
concepts[12].id	https://openalex.org/C138885662
concepts[12].level	0
concepts[12].score	0.08144035935401917
concepts[12].wikidata	https://www.wikidata.org/wiki/Q5891
concepts[12].display_name	Philosophy
concepts[13].id	https://openalex.org/C41895202
concepts[13].level	1
concepts[13].score	0.06801694631576538
concepts[13].wikidata	https://www.wikidata.org/wiki/Q8162
concepts[13].display_name	Linguistics
concepts[14].id	https://openalex.org/C2524010
concepts[14].level	1
concepts[14].score	0.0
concepts[14].wikidata	https://www.wikidata.org/wiki/Q8087
concepts[14].display_name	Geometry
keywords[0].id	https://openalex.org/keywords/correlative
keywords[0].score	0.7673544883728027
keywords[0].display_name	Correlative
keywords[1].id	https://openalex.org/keywords/signature
keywords[1].score	0.639998197555542
keywords[1].display_name	Signature (topology)
keywords[2].id	https://openalex.org/keywords/soft-tissue-sarcoma
keywords[2].score	0.5806832313537598
keywords[2].display_name	Soft tissue sarcoma
keywords[3].id	https://openalex.org/keywords/sarcoma
keywords[3].score	0.48752138018608093
keywords[3].display_name	Sarcoma
keywords[4].id	https://openalex.org/keywords/soft-tissue
keywords[4].score	0.4454762935638428
keywords[4].display_name	Soft tissue
keywords[5].id	https://openalex.org/keywords/medicine
keywords[5].score	0.4198082387447357
keywords[5].display_name	Medicine
keywords[6].id	https://openalex.org/keywords/internal-medicine
keywords[6].score	0.37550005316734314
keywords[6].display_name	Internal medicine
keywords[7].id	https://openalex.org/keywords/oncology
keywords[7].score	0.36900174617767334
keywords[7].display_name	Oncology
keywords[8].id	https://openalex.org/keywords/computer-science
keywords[8].score	0.33658313751220703
keywords[8].display_name	Computer science
keywords[9].id	https://openalex.org/keywords/surgery
keywords[9].score	0.21260696649551392
keywords[9].display_name	Surgery
keywords[10].id	https://openalex.org/keywords/pathology
keywords[10].score	0.20856687426567078
keywords[10].display_name	Pathology
keywords[11].id	https://openalex.org/keywords/mathematics
keywords[11].score	0.13109853863716125
keywords[11].display_name	Mathematics
keywords[12].id	https://openalex.org/keywords/philosophy
keywords[12].score	0.08144035935401917
keywords[12].display_name	Philosophy
keywords[13].id	https://openalex.org/keywords/linguistics
keywords[13].score	0.06801694631576538
keywords[13].display_name	Linguistics
language	en
locations[0].id	doi:10.1158/1078-0432.27754869
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.27754869
locations[1].id	pmh:oai:figshare.com:article/27754869
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Image
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/figure/Supplementary_Figure_S5_from_Predictive_and_Dynamic_Signature_for_Antiangiogenics_in_Combination_with_a_PD1_Inhibitor_in_Soft-Tissue_Sarcoma_Correlative_Studies_Linked_to_the_IMMUNOSARC_Trial/27754869
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5009957675
authorships[0].author.orcid	https://orcid.org/0000-0002-6514-2419
authorships[0].author.display_name	David S. Moura
authorships[0].author_position	first
authorships[0].raw_author_name	David S. Moura
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5090497827
authorships[1].author.orcid	https://orcid.org/0000-0002-3006-1360
authorships[1].author.display_name	Jesús M. López Martí
authorships[1].author_position	middle
authorships[1].raw_author_name	Jesus M. Lopez-Marti
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5073160270
authorships[2].author.orcid	https://orcid.org/0000-0003-4886-4214
authorships[2].author.display_name	Iva Benešová
authorships[2].author_position	middle
authorships[2].raw_author_name	Iva Benesova
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5040430517
authorships[3].author.orcid	https://orcid.org/0000-0002-7628-8050
authorships[3].author.display_name	Carlos E. de Andrea
authorships[3].author_position	middle
authorships[3].raw_author_name	Carlos de Andrea
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5060758473
authorships[4].author.orcid	https://orcid.org/0000-0001-8893-8471
authorships[4].author.display_name	Davide di Lernia
authorships[4].author_position	middle
authorships[4].raw_author_name	Davide di Lernia
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5081453760
authorships[5].author.orcid	https://orcid.org/0000-0003-2475-0706
authorships[5].author.display_name	Serena Lacerenza
authorships[5].author_position	middle
authorships[5].raw_author_name	Serena Lacerenza
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5015310203
authorships[6].author.orcid	https://orcid.org/0000-0002-5642-3796
authorships[6].author.display_name	José L. Mondaza-Hernández
authorships[6].author_position	middle
authorships[6].raw_author_name	Jose L. Mondaza-Hernandez
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5028392008
authorships[7].author.orcid	https://orcid.org/0000-0003-0711-8979
authorships[7].author.display_name	Marta Martín‐Ruíz
authorships[7].author_position	middle
authorships[7].raw_author_name	Marta Martin-Ruiz
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5015152832
authorships[8].author.orcid	https://orcid.org/0000-0002-7179-5360
authorships[8].author.display_name	Marta Ramírez-Calvo
authorships[8].author_position	middle
authorships[8].raw_author_name	Marta Ramirez-Calvo
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5050031420
authorships[9].author.orcid	https://orcid.org/0000-0001-5515-569X
authorships[9].author.display_name	Giovanni Grignani
authorships[9].author_position	middle
authorships[9].raw_author_name	Giovanni Grignani
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5020381519
authorships[10].author.orcid	https://orcid.org/0000-0002-0997-2573
authorships[10].author.display_name	Javier Martínez‐Trufero
authorships[10].author_position	middle
authorships[10].raw_author_name	Javier Martinez-Trufero
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5081736939
authorships[11].author.orcid	https://orcid.org/0000-0002-7257-5642
authorships[11].author.display_name	Andrés Redondo
authorships[11].author_position	middle
authorships[11].raw_author_name	Andres Redondo
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5009531132
authorships[12].author.orcid	https://orcid.org/0000-0003-4107-8616
authorships[12].author.display_name	Claudia Valverde
authorships[12].author_position	middle
authorships[12].raw_author_name	Claudia Valverde
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5060954086
authorships[13].author.orcid	https://orcid.org/0000-0002-1742-8666
authorships[13].author.display_name	Silvia Stacchiotti
authorships[13].author_position	middle
authorships[13].raw_author_name	Silvia Stacchiotti
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5085410610
authorships[14].author.orcid	https://orcid.org/0000-0003-1066-3951
authorships[14].author.display_name	Antonio López–Pousa
authorships[14].author_position	middle
authorships[14].raw_author_name	Antonio Lopez-Pousa
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5076792937
authorships[15].author.orcid	https://orcid.org/0000-0002-7369-8388
authorships[15].author.display_name	José Antonio López‐Guerrero
authorships[15].author_position	middle
authorships[15].raw_author_name	José A. Lopez-Guerrero
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5006074198
authorships[16].author.orcid	https://orcid.org/0000-0001-9062-077X
authorships[16].author.display_name	Antonio Gutiérrez
authorships[16].author_position	middle
authorships[16].raw_author_name	Antonio Gutierrez
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5008597695
authorships[17].author.orcid	https://orcid.org/0000-0002-8785-4898
authorships[17].author.display_name	Victor Encinas-Tobajas
authorships[17].author_position	middle
authorships[17].raw_author_name	Victor Encinas-Tobajas
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5013226419
authorships[18].author.orcid	https://orcid.org/0000-0002-5864-762X
authorships[18].author.display_name	Nadia Hindi
authorships[18].author_position	middle
authorships[18].raw_author_name	Nadia Hindi
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5041240875
authorships[19].author.orcid	https://orcid.org/0000-0002-7163-7071
authorships[19].author.display_name	Dario Sangiolo
authorships[19].author_position	middle
authorships[19].raw_author_name	Dario Sangiolo
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5080626646
authorships[20].author.orcid	https://orcid.org/0000-0001-7530-3207
authorships[20].author.display_name	José A. López-Martín
authorships[20].author_position	middle
authorships[20].raw_author_name	Jose A. Lopez-Martin
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5075239221
authorships[21].author.orcid	https://orcid.org/0000-0003-4976-9534
authorships[21].author.display_name	Zuzana Střížová
authorships[21].author_position	middle
authorships[21].raw_author_name	Zuzana Ozaniak Strizova
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5023576532
authorships[22].author.orcid	https://orcid.org/0000-0001-7350-6916
authorships[22].author.display_name	Javier Martín‐Broto
authorships[22].author_position	last
authorships[22].raw_author_name	Javier Martin-Broto
authorships[22].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.27754869
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure S5 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10253
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9973999857902527
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Sarcoma Diagnosis and Treatment
related_works	https://openalex.org/W105375074, https://openalex.org/W2339526560, https://openalex.org/W2411966289, https://openalex.org/W4380448608, https://openalex.org/W4319965185, https://openalex.org/W2525295234, https://openalex.org/W2150538964, https://openalex.org/W3112140615, https://openalex.org/W2110516926, https://openalex.org/W2399304731
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1078-0432.27754869
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.27754869
primary_location.id	doi:10.1158/1078-0432.27754869
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.27754869
publication_date	2024-11-15
publication_year	2024
referenced_works_count	0
abstract_inverted_index.as	36
abstract_inverted_index.in	6, 25
abstract_inverted_index.of	13
abstract_inverted_index.(A)	28
abstract_inverted_index.S5.	2
abstract_inverted_index.The	10
abstract_inverted_index.and	22, 29
abstract_inverted_index.was	34
abstract_inverted_index.(B).	32
abstract_inverted_index.PBMC	26
abstract_inverted_index.cell	7
abstract_inverted_index.were	17
abstract_inverted_index.after	19
abstract_inverted_index.tumor	30
abstract_inverted_index.CXCL10	3, 14
abstract_inverted_index.Figure	1
abstract_inverted_index.levels	12
abstract_inverted_index.culture	8
abstract_inverted_index.defined	35
abstract_inverted_index.protein	4, 16
abstract_inverted_index.soluble	15
abstract_inverted_index.cultures	27
abstract_inverted_index.measured	18
abstract_inverted_index.(Students	38
abstract_inverted_index.anti-PD-1	23
abstract_inverted_index.p<0.05	37
abstract_inverted_index.treatment	24
abstract_inverted_index.expression	5, 11
abstract_inverted_index.stimulation	21
abstract_inverted_index.Significance	33
abstract_inverted_index.supernatant.	9
abstract_inverted_index.anti-CD3/CD28	20
abstract_inverted_index.multi-cultures	31
abstract_inverted_index.t-test).</p>	39
abstract_inverted_index.<p>Supplementary	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	23
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5400000214576721
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.42523561
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False